First Page | Document Content | |
---|---|---|
Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injectionAdd to Reading ListSource URL: www.sfcityclinic.orgDownload Document from Source WebsiteFile Size: 359,31 KBShare Document on Facebook |